How do I participate in the Pitching Competition?

All startup pass holders are automatically considered for the MedTech World Pitching Competition. Our team will review every startup pass applicant, and the top 10 companies selected by MedTech World will be invited to pitch live on stage during the summit. No additional application is required — simply secure your Startup Pass and you’ll be in the running.

What are the benefits of the 'StartUp Pass'?

The Startup Pass is designed to give early-stage innovators maximum exposure and access at MedTech World. With this pass, founders receive full access to the summit, networking opportunities, and investor-focused programming — including automatic entry for consideration in our Pitching Competition. Startup pass holders also benefit from direct engagement opportunities with investors, corporates, and industry leaders, helping accelerate partnerships, visibility, and growth within the global MedTech ecosystem.

How long will I get on stage if I’m selected?

Selected startups will receive 3 minutes to pitch followed by 3 minutes of Q&A with our judging panel. This fast-paced format is designed to showcase your solution clearly, highlight your traction, and engage directly with investors and experts.

When is the Startup Pitching Competition?

The Startup Pitch will take place on Friday, 28 August 2026. As one of the key highlights of the afternoon program, this session will spotlight the most promising emerging MedTech innovators in front of investors, industry leaders, and media — making it a prime moment for visibility and momentum.

How else can I present on stage?

Beyond the Pitching Competition, startups can secure a dedicated Presenting Slot, which guarantees stage time and enhanced visibility. This option includes a 6-minute presentation on one of our main stages, a feature across MedTech World media channels, and a recorded conference interview to further amplify your story. It’s an ideal route for founders who want assured exposure and a more in-depth opportunity to present their technology, vision, and traction to investors and industry leaders. If you’re interested, our team can share availability and package details.

Startup Pitch | MedTech World Asia 2026

Meet our MedTech World Asia Pitch Sponsors

Ascend Clinical Research Organisation

Ascend CRO is a full-service Contract Research Organization (CRO) headquartered in Australia serving all of Australasia. We deliver FDA-compliant clinical trials for early-stage medical device companies resulting in lower costs and high-quality data. Close working relationships with regulatory bodies (TGA, FDA, others) and research teams in the US, Europe, Asia and Israel enable us to conduct multi-center trials across diverse therapeutic areas. Staffed by tenured professionals, sponsors can expect deep ties with sites, staff and specialists.

Blue Goat Cyber

Blue Goat Cyber is a medical device cybersecurity firm helping manufacturers accelerate regulatory readiness and deliver safer connected products. With 250+ global and FDA submissions supported and zero cybersecurity rejections, we provide fixed-fee, turnkey support across the total product lifecycle, including threat modeling, penetration testing, SBOM management, and postmarket monitoring

Malta Enterprise

Malta Enterprise (ME) is the economic development agency of the Government of Malta, responsible for attracting foreign direct investment and facilitating the growth of existing businesses in Malta. With roots dating back to the 1950s, the organisation brings decades of experience in industrial and economic development. It also serves as a key adviser to government on economic policy, working closely with major industry stakeholders.

Meet our Global Network of Investors

MedTech Asia is a nexus for a prestigious portfolio of investors converging from all corners of the world, collectively managing assets surpassing 1 billion dollars. These esteemed financial catalysts come from varied industries and backgrounds, united by their passion for advancing healthcare technology. Their presence not only signifies the global reach and influence of our event but also highlights the substantial capital ready to be deployed into innovative MedTech ventures. It’s a testament to the global community’s commitment to driving progress and shaping the future of healthcare at our distinguished summit.

Aegis Capital

Aegis Capital Corporation “Aegis” has been in business for over 35 years catering to the needs of private clients, institutions and corporations. Aegis was founded in 1984 and offers its investment representatives a conflict free service platform and is able to provide a full-range of products and services including investment banking, wealth management, insurance, retirement planning, structured products, private equity, alternatives, equity research, fixed income and special purpose vehicles. Aegis is able to provide quality service through its primary clearing relationship with RBC Correspondent Services whose parent company, Royal Bank of Canada (NYSE:RY), is one of the world’s leading diversified…

Alibaba Entrepreneurs Fund

Alibaba Entrepreneurs Fund is a not-for-profit initiative launched by Alibaba Group in 2015. Our mission is to help Hong Kong based entrepreneurs and young people realize their dreams and visions for their businesses and communities. We are passionate about fostering the entrepreneurial spirit amongst young people. As such, we established in Hong Kong a HK$1 billion fund and in Taiwan a NT$10 billion fund to support entrepreneurs in both markets.

AM Ventures

The leading venture capital firm in industrial 3D printing (additive manufacturing, AM) has an extensive portfolio of more than a dozen successful companies in 6 countries on 3 continents. The team possesses in-depth technology know-how and is well connected with the most experienced experts in the field. As an investment partner, the company provides a globally leading ecosystem of sustainable investments in AM and introduces entrepreneurs to a large pool of industry veterans, each one with decades of experience in engineering, manufacturing and executive management. Since 2021, AM Ventures is set up as a venture capital fund with the LANGER…

Anthro Ventures

Anthro Ventures is a healthcare and life sciences investment firm whose mission is to humanize healthcare investments. Our approach to investing focuses on the context in which healthcare is delivered to create value for patients, providers and payers. We seek to partner with entrepreneurs transforming the practice of medicine by improving patient outcomes and lowering costs. We invest in clinical to growth stage companies across medical devices, diagnostics, and healthcare technology. Anthro Ventures is based in Washington, DC.

Arkray & Partners Pte. Ltd.

ARKRAY means “radiance of life.”ARKRAY tries to bring “radiance of life” to all people with its science technology.’ARKRAY’ is a combination of two words: ARK and RAY. ‘ARK’ is an ark or a large wooden boat. As Noah’s ark saved every kind of living creatures in the Old Testament of the Christian Bible, an ark is considered a symbol of life. ‘RAY’ is another word for brilliance. It also means rays of light, a flash, and a twinkle. Together they mean the ‘shine of life’.

Ascend Capital Partners

Ascend Capital Partners is a leading international venture capital firm committed to world-class investment opportunities with innovative companies who have potential to grow and expand internationally. Our team has significant skin in the game, placing ourselves shoulder-to-shoulder with entrepreneurs. We have extensive regional and international networks, and insight into Asian and Western markets.

August Global Partners

August Global Partners (AGP) is a growth-oriented fund management company headquartered in Singapore, serving a diverse base of financial investors, conglomerates, and institutions globally. Leveraging decades of international investment experience and an extensive network across Asia and beyond, AGP provides value-added capital and strategic support to its portfolio companies.

Aulis Capital

Aulis Capital is a global investment firm focusing on the health care industry. We partner with early and growth stage companies, leveraging scientific, analytical and investment expertise to accelerate innovations that improve patient care and advance medical technology

B Capital

B Capital invests globally in extraordinary founders and businesses shaping the future through technology. With more than $9 billion in assets under management and dedicated stage-based funds, the firm focuses on seed to early- and late-stage venture growth investments, primarily in the technology, healthcare and resilience tech sectors. Founded in 2015, B Capital has an integrated, global team across nine locations in the U.S. and Asia. The firm’s value-add platform, together with the consulting expertise of its strategic partner, The Boston Consulting Group, provides entrepreneurs with the tools and resources to scale quickly and efficiently, expand into new markets and…

Bioscience Equity Partners

Bioscience Equity Partners (BEP), a leading global investment bank, fund and fund manager exclusive to the life sciences sector. At BEP, we not only manage funds for prominent sovereign wealth funds in the Middle East and leading corporate venture capital entities solely focused on early stage life science companies , but we also own and operate our own fund Antisoma. Our primary focus is providing venture capital, equity, and debt financing, tailored to accelerate growth and innovation.

Buenavista Equity Partners

Buenavista Equity Partners is an independent asset manager founded in 1996 that operates in the middle-market segment. It currently manages more than €1.3 billion through different Private Equity, Infrastructure and Venture Capital vehicles.

CBC

Headquartered in Singapore, CBC Group is Asia’s largest healthcare-dedicated asset management firm, with an AUM of US$10.5billion. With a diversified, multi-product strategy, CBC Group is focused on platform-building, buyout, private credit and royalties, and real estate, across the healthcare space, including pharmaceutical, biotech, medical technology, and healthcare services.

CDH Investments

Established in 2002, CDH Investments is one of the leading alternative investment fund managers focused on China today with over US$19 billion of assets under management, as of December 31, 2019. CDH was founded by WU Shangzhi, JIAO Shuge and four other investment professionals who worked together in the direct investment department of China International Capital Corporation beginning in 1995.

CEC Capital

Founded in 2000, CEC Capital Group (formerly known as China eCapital Corporation) is a leading investment bank in China with a core focus on the TMT, consumer and healthcare sectors.Headquartered in Beijing with offices in Shanghai, Los Angeles and San Francisco, we provide M&A, capital raising, and asset management services to our clients both in and outside of China.To ensure that our clients have the best access to capital markets, we have developed an unparalleled network of institutional investors and corporate buyers. Our ECM team systematically cover over 7,000 institutional investors, which range from large conglomerates and industry heavyweights, public…

Chaanakya Capital

At Chaanakya Capital, we invest in transformative neurotech and neuro-focused medtech startups that are reshaping the future of healthcare. We believe great science deserves great support, and we back innovative founders who are often overlooked by traditional venture channels.With a focus on equity, innovation, and real-world impact, we bring deep sector expertise and a global network to help bold ideas scale — delivering lasting value to our companies and strong returns to our investors.

City University of Hong Kong

Located in the heart of Hong Kong, City University of Hong Kong (CityUHK) has a well-earned reputation as an innovative hub for research and professional education and for addressing global issues and empowering positive change.

CK Life Sciences

CK Life Sciences Int’l., (Holdings) Inc. is listed on The Stock Exchange of Hong Kong Limited. With the mission of improving the quality of life, CK Life Sciences is engaged in healthcare research and development, with operating businesses that enable its R&D sustainability. CK Life Sciences is a member of the CK Hutchison Group.

CorVista Health

CorVista Health is transforming cardiovascular care with the CorVista System, a non-invasive point-of-care diagnostic technology, that shortens the path from symptoms to diagnosis, empowering earlier treatment and better patient outcomes. The CorVista System leverages proprietary machine-learned algorithms and robust clinical data to deliver results providers can trust.

Cunningham Investment Group

Cunningham Investment Group (CIG) is a private partnership established in 2014. It operates under the principles of value investing, focusing on identifying exceptional companies that are undervalued and holding onto them for the long term, ideally for a lifetime. The group aims to preserve and increase the capital of a growing number of like-minded partners.

Dawn Medical Technologies

At Dawn MedTech, we provide a carefully curated selection of high-quality medical products across Urology, General Surgery, and Gastroenterology. Our portfolio is designed to support healthcare professionals with reliable, effective, and regulatory-compliant solutions that enhance patient care. Explore our product categories to find the right solutions for your medical practice.

Dendrion Ventures (Wanke Family Office)

Evergreen capital for innovative and impactful MedTech opportunities

East Ventures

East Ventures is a pioneering and leading sector-agnostic venture capital firm. Founded in 2009, East Ventures has transformed into a holistic platform that provides multi-stage investment, from Seed to Growth stage investments, for over 300 tech companies across Southeast Asia.

EC5 Capital Pte Ltd

EC5 Capital is a Singapore-based single family office investing across private markets through direct deals, co-investments, and selective fund commitments. While stage-agnostic and sector-flexible, we prioritize direct investments where we can contribute strategic value through our global network.

EDBI

EDBI operates under SG Growth Capital, the investment platform of the Singapore Economic Development Board (EDB) and Enterprise Singapore. We invest in high-growth global technology companies and industry leaders looking to scale in Singapore and across Asia.

EQT Partners

A global private markets firm. 30+ years of unlocking returns and growth for investors beyond public markets.

Fong Capital Partners

Fong Capital Partners (FCP) is a dual-currency private equity investment firm specializing in the technology and healthcare sectors. With offices in Hong Kong, Beijing and Shanghai, FCP’s core team has collaborated for over a decade, accumulating extensive experience managing both USD and RMB funds. The AUM the firm managed has exceeded USD 1 billion. Guided by an investment philosophy that emphasizes navigating economic cycles, deep industry engagement, precise strategic positioning, and responsible investment, FCP has consistently delivered robust and sustained returns to investors over the past ten years, earning recognition from institutional investors internationally.

Gobi Partners

Since 2002, Gobi has overseen US$2 billion AUM across more than 30 funds, and its team of 80+ people now manages a portfolio of over 400 companies from 18 locations. Over the last two decades, the firm has supported emerging ecosystems and built a proven track record of 75 exits and counting. This has resulted in deep strategic partnerships with the most prominent sovereign wealth funds, financial institutions, corporate investors, and family offices in Asia.

Govin Capital

Singapore-headquartered Digital Health and Edtech investment company with a focus on provising smart capital and mentorship to innovatve startups across Singapore, India and USA.

GP West

GP West is one of Western Australia’s leading networks of medical centres, founded by Dr. Kiran Puttappa, a clinician, entrepreneur and healthcare leader with over 20 years of experience in Australia.As Founder & CEO, RACGP WA Board Member and former AHPRA panel member, Dr. Puttappa has built GP West into a trusted network of over 20 centres. He is also a strong mentor to doctors—particularly IMGs—and a pioneer in digital health, driving AI-enabled solutions to improve efficiency and reduce administrative burden for clinicians.

Greenwillow Capital

Greenwillow Capital Management is a fund and asset management company, with a primary focus on real estate and venture capital investments in Asia’s fast-growing emerging markets.

GT Healthcare Capital Partners

GT Healthcare Capital Partners is a healthcare investment firm backing global leaders and bridging innovative technologies across continents to transform patient care.

Impact Capital Asset Management

We create wealth through strategic and impactful capital management.

IQT

IQT is the not-for-profit strategic investor the U.S. national security community and America’s allies have relied upon for over 25 years to anticipate their technology questions and needs and achieve solutions. IQT identifies, evaluates, and leverages emerging commercial technologies to deliver best-in-class capabilities, insights, and other services to government partners through a unique global investment platform.

Iskandar Investment Berhad

Iskandar Investment Berhad (IIB) is an investment holding company incorporated in November 2006 to catalyse the strategic development of Iskandar Malaysia. IIB focuses on Iskandar Puteri (previously known as Nusajaya) or Flagship Zone B.To ensure that Iskandar Malaysia grows into an inclusive and sustainable future metropolis, IIB will continue to develop high- impact projects in the education, tourism and leisure, creative, and health and wellness sectors to cultivate an attractive investment destination and a vibrant, livable region. Khazanah Nasional Berhad (KNB), Employees Provident Fund (EPF) and Kumpulan Prasarana Rakyat Johor (KPRJ) are the shareholders of IIB.

Jungle Ventures

We started Jungle in 2012 with the goal of creating a different kind of venture capital firm, by not trying to be everything to everyone. We have done this by focusing on fewer investments than our peers and only targeting entrepreneurs who have ambitions to build regional if not global category leaders.

Junson Capital

Junson Capital is a prominent global investment management company. Anchored by permanent capital Junson’s business covers real estate, public markets, private equity and alternative investments with a global portfolio. Junson currently has offices in Hong Kong, New York, Singapore and Palo Alto.

Marubeni Consumer Platform

Growth capital platform focused on businesses driven by the needs of Next Generation Consumers in South East Asia.

MedSight Capital

The MedSight Advantage. We bridge the gap between clinical breakthrough and commercial scaleWe bridge the gap between clinical breakthrough and commercial scaleThe MedSight AdvantageWThe MedSight AdvantageWe bridge the gap between clinical breakthrough and commercial scaleThe MedSig bridge the gap between clinical breakthrough and commercial scalee bridge the gap between clinical breakthrough and commercial scaleTechnology

MedTech Syndicates

MedTech Syndicates” (MTS) is a closed members only site designed to form syndicates exclusively for clinicians that allows for the review, evaluation and investment in early start stage MedTech companies in a clinical area that they have expert knowledge or in other clinical areas with the knowledge of other members who endorse the product/service.

Mergerscorp

At MergersCorp™ M&A International we help our clients confidentially buy and sell privately held businesses, aligning the interests of all parties for mutual success and satisfaction.

Mucker Capital

Not in Silicon Valley? Not a problem. Mucker Capital invests in Seed and Series A stage companies outside Silicon Valley.

Navis Capital

Navis Capital Partners was founded in 1998 in order to make private equity investments in buyouts, recapitalisations and financial restructurings in Asia, particularly on enterprises with a strong presence in South and Southeast Asia.

NF Trinity | Nan Fung Family Office

Nan Fung Trinity (HK) Limited (“NF Trinity”) is the financial investment arm of Nan Fung Group (“Group”), focusing on multiple asset classes including public securities, structured products, private direct investments and private market funds.Nan Fung Group is a privately-held conglomerate headquartered in Hong Kong. Since its founding in 1954, it has transformed from a Hong Kong textile manufacturer to a highly respected international business conglomerate with global interests in property markets, financial investments, life sciences, shipping and a diverse range of business partnerships. For more information, visit: https://www.nanfung.com

Novo Holdings

Novo Holdings is a holding and investment company that is responsible for managing the assets and the wealth of the Novo Nordisk Foundation, one of the world’s largest philanthropic enterprise foundations. Novo Holdings is the controlling shareholder of Novo Nordisk A/S and Novonesis A/S and manages an investment portfolio, with a long-term return perspective. In addition to managing a broad portfolio of equities, bonds, real estate, infrastructure and private equity assets, Novo Holdings is a world-leading life sciences investor. Through its Seeds, Venture, Growth, Principal and Planetary Health Investments teams, Novo Holdings invests in life science companies at all stages of…

OCBC

OCBC Hong Kong is a subsidiary of OCBC Group, the second largest financial services group in Southeast Asia by assets. We provide comprehensive financial solutions across corporate banking, retail banking and wealth management services, serving as a vital gateway for business flows between ASEAN and Greater China. Headquartered in Singapore, OCBC Hong Kong has a rich heritage dating back to 1923, when the first branch office was established in Hong Kong. In 2023, OCBC Group unified its brand across core markets, including Hong Kong, strengthening its One Group strategy to harness the vast opportunities within the ASEAN-Greater China corridor. Guided…

Optellum

Optellum is a lung health company developing the lung precision care platform to redefine the efficient management, early diagnosis, and optimal care of lung disease patients.

PERSPECTIV VENTURES

Venture Capital funding for dynamic startups and young emerging companies in the sectors of+ Healthtech and Medtech+ Fintech & Blockchain+ AI & Robotics.Funding focused on the seed and early stage of growth of these venture-backed companies.We trust our ability to pick the raw diamonds and polish them into gems.

Phillip Private Equity Pte Ltd

Phillip Private Equity, previously known as ECICS Management Pte Ltd* is one of the leading private equity firms in Singapore. We provide capital in the form of equity and debt, to innovative enterprises across select stages, sectors and geographies. We work closely with our investee companies to accelerate their growth and help them achieve their potential. Our goal is to create businesses with lasting and significant value.

Pivotal Life Sciences

At Pivotal Life Sciences, we invest in the brightest minds in life sciences. As a global investment platform dedicated to fostering growth and innovation, we leverage our diverse expertise and the long-term capital commitment from the Nan Fung Group to partner with scientists, entrepreneurs, and thought leaders on drug discovery, development, and growth opportunities.

Ploutos Strategic Investments

STRATEGIC STRUCTURED FINANCIAL SOLUTIONS. FOR ULTRA HIGH NET WORTH INDIVIDUALS

Plug and Play

We scout the globe to identify innovative startups with game-changing technologies. Whether it’s an accelerator, pilot project, or investment opportunity, our team takes you to success.

Polaris Partners

Exceptional entrepreneurs. Remarkable bonds. Extraordinary companies. Since 1996, Polaris has been guided by the fundamental beliefs that people come first and true partnerships make all the difference. Rooted in mutual respect and a shared passion for innovation, our relationships with outstanding visionaries principally in technology and healthcare have helped to change the world for the better.

Quadria Capital

Quadria Capital is Asia’s leading healthcare private equity firm, managing over US$4.3 billion in assets. We maximise returns by investing in high-growth healthcare opportunities across South and Southeast Asia, spanning healthcare delivery, life sciences, medical technology, and associated healthcare services.

Raven Capital

From discovery to delivery, whether we originate, accelerate or rejuvenate, Raven’s goal is to turn scientific breakthroughs into transformative therapies and get them quickly, safely, and efficiently to the people that need them most. Raven’s experienced scientists, operators, and healthcare innovators have deep sector expertise across therapeutics, diagnostics, devices and services. They have brought hundreds of therapeutics into development, managed hospital systems, optimized clinical trials and navigated payor and regulatory systems to deliver patient impact – and they are ready to work with you.

Ryoden Medical Holdings Ltd

Ryoden Development Limited is an investment management company based out of 169 Electric Road, Hong Kong, Hong Kong Island, Hong Kong.

Sanara Capital

Sanara Capital is a dedicated Health-Tech fund established in 2023, specializing in Digital Health, Bio-Convergence, and Medical Devices. Sanara is focused on A & B financing rounds of Israeli-related startups in Israel and abroad.We are a follow-on fund of Sanara Ventures, a seed-stage investment platform established in 2015 and backed by industry leaders Philips and Teva, with nearly 20 active portfolio companies in both funds.

StateSquare Capital

StateSquare Capital is a Singapore-headquartered private equity firm with offices across Asia and Europe. The firm specializes in control investments focused on operational transformation and long-term value creation. StateSquare partners with niche leaders across global supply and service chains, spanning data and knowledge-based services, industrial technology, products, and healthcare. The firm targets mid-market opportunities, building industry leaders worldwide through organic growth acceleration and buy-and-build strategies.

The Sylvan Group

The Sylvan Group is a leading independent private equity investment firm based out of Singapore and Seoul, backed by members of the Hyundai Family. The firm is advised by a prestigious Board of Advisors which includes the Rockefeller family. Our core focus is on deep-value companies with strong ESG-compliance and Impact across the Asia-Pacific region.

Tiger Jade Pebble Accelerator

Pebble is a boutique accelerator building Hong Kong into a global biomedical nexus, bridging the world’s largest patient population with the capital and expertise to reach them.

TPG Capital (S) Pte. Ltd.

TPG (Nasdaq: TPG) is a leading global alternative asset management firm, founded in San Francisco in 1992, with $306 billion of assets under management and investment and operational teams around the world. TPG invests across a broadly diversified set of strategies, including private equity, impact, credit, real estate, and market solutions, and our unique strategy is driven by collaboration, innovation, and inclusion. Our teams combine deep product and sector experience with broad capabilities and expertise to develop differentiated insights and add value for our fund investors, portfolio companies, management teams, and communities.

Tramway Ventures

Breakthrough Technologies and R&D – It’s in our DNA. Embedded in the core of New Mexico’s DNA is a rich history of cutting-edge research and discovery in the vast fields of science, engineering, and technology. Coinciding with the dawn of the atomic age, the US built world-class research institutions and invested heavily to broaden the state’s R&D infrastructure. Today, New Mexico is home to three national research laboratories and three research universities that power the engine of our technology corridor.

Verge HealthTech Fund

We seek and support founders globally who are creating transformative health tech companies today that will shape our vision of tomorrow. We do this by investing in people at the earliest stages, and actively partnering with them to build innovative and valuable solutions that make quality healthcare accessible for all.

VinaCapital Pte Ltd

VinaCapital is a leading investment management firm in Vietnam with a diversified portfolio of nearly USD 4 billion in assets under management. Founded in 2003, our team brings extensive international finance and investment experience to the firm. Our mission is to produce superior returns for investors by using our experience and knowledge to identify the key trends and opportunities that emerge as Vietnam continues to develop its economy. To achieve this, VinaCapital has industry-leading asset class teams covering capital markets, private equity, fixed income, venture capital, real estate, and energy.

VMS Group

VMS Group was founded in 2006 and since then has built close relationships with a handful of large anchor investors, including some of the largest families in Hong Kong. Apart from managing over US$4 billion across its three in-house strategies – Private Equity, Real Estate and Structured Finance, it has also seeded or accelerated other asset managers through strategic partnerships across Venture Capital and Hedge Fund strategies with another US$6 billion under management (as of 30 November 2023).

Zaka VC

Founded as a family office back in 2019, ZAKA has rapidly become one of the most active investors in Europe. Since 2024, ZAKA operates in a VC fund structure with its first fund sized €15M; and successfully oversubscribed. Due to increasing activity and network in the US and Canada, ZAKA